Fundz

Elevara Medicines Appoints Dr. Mai-Britt Zocca as Chief Executive Officer

PRIVATEJul 14, 2026

Position

Chief Executive Officer

Company

Elevara Medicines

Mai-Britt Zocca
LondonBiotechnologyHealth Care

Description

Elevara Medicines has announced the appointment of Dr. Mai-Britt Zocca as CEO, effective 1 July 2026. She will succeed the founder and outgoing CEO Emma Tinsley, who will transition to a Non-Executive Director role

Quick answer

Elevara Medicines Appoints Dr. Mai-Britt Zocca as Chief Executive Officer (July 14, 2026). Elevara Medicines is based in London, England, United Kingdom.

Who is the new Chief Executive Officer at Elevara Medicines?
Elevara Medicines named Mai-Britt Zocca Chief Executive Officer, announced July 14, 2026.
What did Elevara Medicines announce on July 14, 2026?
Elevara Medicines has announced the appointment of Dr. Mai-Britt Zocca as CEO, effective 1 July 2026.
What does Elevara Medicines do?
Elevara Medicines is a clinical-stage biotech company focused on developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases.
Where is Elevara Medicines based?
Elevara Medicines is based in London, England, United Kingdom.
Which similar companies made leadership changes around the same time?
ViCentra B.V (July 14, 2026), Ovid Therapeutics (July 14, 2026), Ironwood Pharmaceuticals (July 14, 2026) and Illuminare Biotechnologies (July 14, 2026) also announced leadership changes within 45 days of Elevara Medicines.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Elevara Medicines, and when

A new leader at Elevara Medicines brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Elevara Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elevara Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elevara Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elevara Medicines

Location

London, England, United Kingdom

About

Elevara Medicines is a clinical-stage biotech company focused on developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases. The company's lead program, ELV001, is an innovative oral CDK4/6 inhibitor that targets synovial fibroblasts, aiming to disrupt traditional treatment paradigms. Elevara's goal is to provide effective options for patients who do not achieve disease remission with current immune-targeted therapies. The company collaborates with various investors and has exclusive rights to develop ELV001 from Teijin Pharma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elevara Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Elevara Medicines's next move

Learn about Strategic plan

Elevara Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.